Suppr超能文献

营养补充剂在女性不孕症中的作用:一项伞状综述和分层证据综合分析

The Role of Nutrient Supplements in Female Infertility: An Umbrella Review and Hierarchical Evidence Synthesis.

作者信息

Pandey Chhiti, Maunder Alison, Liu Jing, Vaddiparthi Vaishnavi, Costello Michael F, Bahri-Khomami Mahnaz, Mousa Aya, Ee Carolyn

机构信息

NICM Health Research Institute, Western Sydney University, Penrith, NSW 2751, Australia.

Women's Health, University of New South Wales and Royal Hospital for Women and Monash IVF, Sydney, NSW 2031, Australia.

出版信息

Nutrients. 2024 Dec 27;17(1):57. doi: 10.3390/nu17010057.

Abstract

BACKGROUND AND OBJECTIVES

Nutrient supplements are commonly used to improve fertility outcomes by women with infertility trying to conceive spontaneously or utilising medically assisted reproduction (MAR). However, despite their widespread use and perceived safety, there is a lack of clear guidance on the efficacy and safety of these supplements for female infertility. The aim of this umbrella review was to identify the best available and most recent evidence on the efficacy and safety of nutrient supplements for female infertility to provide evidence-based guidance for clinicians and reproductive couples.

METHODS

Five electronic databases were searched for umbrella reviews, meta-analyses, and systematic reviews of randomised controlled trials on nutrient supplements for female infertility, published from August 2017 to January 2024. The primary outcomes were live birth, and clinical and biochemical pregnancy rates. Secondary outcomes were adverse effects including miscarriage and ectopic or multiple pregnancy. Quality assessment was performed using the A MeaSurement Tool to Assess systematic Reviews Version 2.0 (AMSTAR 2), and the certainty of evidence for outcomes were assessed using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach, where possible.

RESULTS

Four meta-analyses were included. Multiple micronutrients and antioxidants increased live birth rates in women utilising MAR and/or trying to conceive spontaneously compared to placebo, standard or no treatment (odds ratio (OR) 2.59 and 1.81 respectively) with very low certainty evidence. L-carnitine, coQ10, melatonin, myo-inositol, NAC and vitamin D increased clinical pregnancy rates in women with PCOS and/or undergoing MAR compared to placebo, standard or no treatment (odds ratio (OR) 11.14, 2.49, 1.66, relative risk (RR) 1.52, OR 2.15, and 1.49 respectively) with very low certainty evidence. Vitamin D did not increase biochemical pregnancy rates in women utilising MAR with very low certainty evidence. NAC, vitamin D, and pooled antioxidants had no effect on miscarriage rates or multiple pregnancy rates in women trying to conceive spontaneously or utilising MAR, with low to very low certainty evidence. Pooled antioxidants had no effect on ectopic pregnancy rates in women trying to conceive spontaneously or utilising MAR, with low certainty evidence.

CONCLUSIONS

The available evidence is insufficient to recommend nutrient supplementation to improve female infertility in women trying to conceive naturally and those utilising MAR. However, there is currently no indication that these nutrients pose any risk of significant harm.

REGISTRATION

PROSPERO (CRD42022365966) 20 October 2022.

摘要

背景与目的

营养补充剂被不孕女性广泛用于改善生育结局,这些女性或是尝试自然受孕,或是采用医学辅助生殖(MAR)技术。然而,尽管营养补充剂被广泛使用且被认为安全,但对于这些补充剂在女性不孕症治疗中的疗效和安全性,仍缺乏明确的指导意见。本系统综述的目的是确定关于营养补充剂治疗女性不孕症的疗效和安全性的最佳和最新证据,为临床医生和不孕夫妇提供循证指导。

方法

检索了五个电子数据库,查找2017年8月至2024年1月发表的关于营养补充剂治疗女性不孕症的系统综述、荟萃分析和随机对照试验的系统评价。主要结局为活产、临床妊娠率和生化妊娠率。次要结局为不良反应,包括流产、异位妊娠或多胎妊娠。使用评估系统评价的测量工具2.0版(AMSTAR 2)进行质量评估,并尽可能使用推荐分级的评估、制定和评价(GRADE)方法评估结局证据的确定性。

结果

纳入了四项荟萃分析。与安慰剂、标准治疗或不治疗相比,多种微量营养素和抗氧化剂可提高采用MAR技术和/或尝试自然受孕的女性的活产率(优势比分别为2.59和1.81),证据确定性极低。与安慰剂、标准治疗或不治疗相比,左旋肉碱、辅酶Q10、褪黑素、肌醇、N-乙酰半胱氨酸(NAC)和维生素D可提高多囊卵巢综合征(PCOS)女性和/或接受MAR技术治疗的女性的临床妊娠率(优势比分别为11.14、2.49、1.66,相对危险度为1.52,优势比分别为2.15和1.49),证据确定性极低。证据确定性极低表明,维生素D不能提高接受MAR技术治疗的女性的生化妊娠率。证据确定性低至极低表明,NAC、维生素D和复合抗氧化剂对自然受孕或接受MAR技术治疗的女性的流产率或多胎妊娠率没有影响。证据确定性低表明,复合抗氧化剂对自然受孕或接受MAR技术治疗的女性的异位妊娠率没有影响。

结论

现有证据不足以推荐使用营养补充剂来改善自然受孕女性和接受MAR技术治疗的女性的不孕症。然而,目前没有迹象表明这些营养素会造成任何重大伤害风险。

注册信息

PROSPERO(CRD42022365966),2022年10月20日。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c612/11722770/a5966486fbd3/nutrients-17-00057-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验